{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:57:26Z","timestamp":1789502246050,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.seizure.2016.01.019","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T10:41:14Z","timestamp":1455792074000},"page":"44-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Prescribing trends for sodium valproate in Ireland"],"prefix":"10.1016","volume":"36","author":[{"given":"Sin\u00e9ad","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin P.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.seizure.2016.01.019_bib0175","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0733-8619(18)30075-6","article-title":"Pregnancy, teratogenesis, and epilepsy","volume":"12","author":"Yerby","year":"1994","journal-title":"Neurol Clin"},{"issue":"Suppl 4","key":"10.1016\/j.seizure.2016.01.019_bib0180","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1111\/j.1528-1157.1992.tb06226.x","article-title":"Pregnancy and the risk of teratogenicity","volume":"33","author":"Lindhout","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.01.019_bib0185","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1157.1998.tb01186.x","article-title":"Pregnancies of women with epilepsy: a population-based study in Iceland","volume":"39","author":"Olafsson","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.01.019_bib0190","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs","volume":"344","author":"Holmes","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.seizure.2016.01.019_bib0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2016.01.019_bib0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-1211(98)00084-9","article-title":"Congenital malformations due to anti-epileptic drugs","volume":"33","author":"Kaneko","year":"1999","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.seizure.2016.01.019_bib0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.seizure.2012.01.005","article-title":"Valproate and the risk for congenital malformations: Is formulation and dosage regime important?","volume":"21","author":"Mawhinney","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2016.01.019_bib0210","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs","volume":"344","author":"Hayes","year":"2001","journal-title":"N Eng J Med"},{"issue":"3","key":"10.1016\/j.seizure.2016.01.019_bib0215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.yebeh.2009.04.026","article-title":"Antiepileptic drug use in women of childbearing age","volume":"15","author":"Meador","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.seizure.2016.01.019_bib0220","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0022-3476(81)80743-3","article-title":"Possible teratogenicity of valproic acid","volume":"98","author":"Gomez","year":"1981","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.seizure.2016.01.019_bib0225","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"EURAP study group; Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2016.01.019_bib0230","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yebeh.2011.06.014","article-title":"Fetal antiepileptic drug exposure: motor, adaptive, and emotional\/behavioral functioning at age 3 years","volume":"22","author":"Cohen","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.seizure.2016.01.019_bib0235","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: Adaptive and emotional\/behavioral functioning at age 6years","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"23","key":"10.1016\/j.seizure.2016.01.019_bib0240","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.seizure.2016.01.019_bib0245","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine sodium valproate and carbamazepine","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.seizure.2016.01.019_bib0250","unstructured":"The Medicines and Healthcare Regulatory Authority (MHRA). Medicines related to valproate: risk of abnormal pregnancy outcomeshttps:\/\/www.gov.uk\/drug-safety-update\/medicines-related-to-valproate-risk-of-abnormal-pregnancy-outcomes accessed on line 14\/10\/2015."},{"issue":"10","key":"10.1016\/j.seizure.2016.01.019_bib0255","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1528-1167.2010.02668.x","article-title":"Liverpool and Manchester Neurodevelopment Group LMNDG; Early Cognitive development in children born to women with epilepsy","volume":"51","author":"Bromley","year":"2010","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2016.01.019_bib0260","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2016.01.019_bib0265","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","article-title":"Management issues for women with epilepsy focus on pregnancy (an evidence based review): II. Teratogenesis and perinatal outcomes","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.01.019_bib0270","doi-asserted-by":"crossref","unstructured":"Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, Tudur Smith C, Marson AG. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. The Cochrane Database of Systematic Reviews 2014, Issue 10. Art. No.: CD010236. DOI: 10.1002\/14651858.CD010236.pub2.","DOI":"10.1002\/14651858.CD010236.pub2"},{"key":"10.1016\/j.seizure.2016.01.019_bib0275","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1528-1167.2009.02417.x","article-title":"Examining the prevalence of epilepsy and delivery of epilepsy care in Ireland","volume":"51","author":"Linehan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.01.019_bib0280","first-page":"23","article-title":"Epilepsy and pregnancy","volume":"32","author":"Liggan","year":"2002","journal-title":"Mod Med"},{"issue":"2","key":"10.1016\/j.seizure.2016.01.019_bib0285","first-page":"52","article-title":"Management of epilepsy in the community","volume":"99","author":"Neligan","year":"2006","journal-title":"Ir Med J [serial online]"},{"issue":"6","key":"10.1016\/j.seizure.2016.01.019_bib0290","first-page":"173","article-title":"Epilepsy care in general practice","volume":"102","author":"Varley","year":"2009","journal-title":"Ir Med J"},{"issue":"1","key":"10.1016\/j.seizure.2016.01.019_bib0295","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.seizure.2009.11.002","article-title":"Epilepsy in Ireland: towards the primary-tertiary care continuum","volume":"19","author":"Varley","year":"2010","journal-title":"Seizure"},{"issue":"2.","key":"10.1016\/j.seizure.2016.01.019_bib0300","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.yebeh.2010.10.020","article-title":"The health care journeys experienced by people with epilepsy in Ireland: what are the implications for future service reform and development?","volume":"20","author":"Varley","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"7","key":"10.1016\/j.seizure.2016.01.019_bib0305","first-page":"214","article-title":"Towards the development of integrated epilepsy services: an audit of documented epilepsy care","volume":"104","author":"Varley","year":"2011","journal-title":"Ir Med J"},{"issue":"6","key":"10.1016\/j.seizure.2016.01.019_bib0310","first-page":"173","article-title":"Epilepsy care in general practice","volume":"102","author":"Varley","year":"2009","journal-title":"Irish Medical Journal"},{"key":"10.1016\/j.seizure.2016.01.019_bib0315","unstructured":"European Medicines Agency Alert. 8http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2014\/11\/news_detail_002220.jsp&mid=WC0b01ac058004d5c1. Accessed on online April 2nd 2015."},{"issue":"12 (December)","key":"10.1016\/j.seizure.2016.01.019_bib0320","article-title":"Prescribing Trends in Bipolar Disorder: Cohort Study in the United Kingdom THIN Primary Care Database 1995-2009","volume":"6","author":"Hayes","year":"2011","journal-title":"PLoS one"},{"issue":"6","key":"10.1016\/j.seizure.2016.01.019_bib0325","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/adc.2008.144386","article-title":"Changing trends in antiepileptic drug prescribing in girls of child-bearing potential","volume":"94","author":"Ackers","year":"2009","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1016\/j.seizure.2016.01.019_bib0330","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/bdra.23147","article-title":"Valproate prescriptions for nonepilepsy disorders in reproductive-age women, Birth Defects Research","volume":"97","author":"Adedinsewo","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"2","key":"10.1016\/j.seizure.2016.01.019_bib0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0404.2009.01260.x","article-title":"Changing pat- terns of antiepileptic drug use in pregnant Australian women","volume":"121","author":"Vajda","year":"2010","journal-title":"Acta Neurol Scand"},{"issue":"565","key":"10.1016\/j.seizure.2016.01.019_bib0340","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3399\/bjgp09X453837","article-title":"The changing relationship between neurology and general practice in the UK","volume":"59","author":"Morrish","year":"2009","journal-title":"Br J Gen Pract"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:47:07Z","timestamp":1761011227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131116000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"alternative-id":["S1059131116000418"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2016.01.019","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing trends for sodium valproate in Ireland","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2016.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}